Cocrystal Pharma (COCP)
(Delayed Data from NSDQ)
$1.49 USD
-0.06 (-4.17%)
Updated Apr 29, 2024 10:11 AM ET
NA Value
NA Growth NA Momentum NA VGMDetailed Estimates
EPS Estimates
Exp Earnings Date | 5/20/24 |
---|---|
Current Quarter | -0.54 |
EPS Last Quarter | -0.44 |
Last EPS Surprise | 22.81% |
ABR | 1.00 |
Earnings ESP
|
0.00% |
---|---|
Current Year | -2.30 |
Next Year | -1.96 |
EPS (TTM) | -1.99 |
P/E (F1) | NA |
Sales Estimates
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | NA | NA | NA | NA |
# of Estimates | NA | NA | NA | NA |
High Estimate | NA | NA | NA | NA |
Low Estimate | NA | NA | NA | NA |
Year ago Sales | 0.00M | 0.00M | NA | NA |
Year over Year Growth Est. | NA | NA | NA | NA |
Earnings Estimates
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | -0.54 | -0.57 | -2.30 | -1.96 |
# of Estimates | 2 | 2 | 2 | 2 |
Most Recent Consensus | -0.52 | -0.56 | -2.28 | -2.44 |
High Estimate | -0.52 | -0.56 | -2.28 | -1.47 |
Low Estimate | -0.56 | -0.57 | -2.31 | -2.44 |
Year ago EPS | -0.64 | -0.50 | -1.87 | -2.30 |
Year over Year Growth Est. | 15.63% | -14.00% | -22.99% | 14.78% |
Agreement - Estimate Revisions
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Up Last 7 Days | 0 | 0 | 0 | 0 |
Up Last 30 Days | 1 | 1 | 1 | 0 |
Up Last 60 Days | 1 | 1 | 1 | 0 |
Down Last 7 Days | 0 | 0 | 1 | 1 |
Down Last 30 Days | 0 | 0 | 1 | 1 |
Down Last 60 Days | 0 | 0 | 1 | 1 |
Magnitude - Consensus Estimate Trend
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Current | -0.54 | -0.57 | -2.30 | -1.96 |
7 Days Ago | -0.56 | -0.57 | -2.18 | -1.46 |
30 Days Ago | -0.57 | -0.58 | -2.20 | -1.45 |
60 Days Ago | -0.57 | -0.58 | -2.20 | -1.45 |
90 Days Ago | -0.57 | -0.58 | -1.92 | -0.65 |
Upside - Most Accurate Estimate Versus Zacks Consensus
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Most Accurate Estimate | -0.54 | -0.57 | -2.30 | -1.96 |
Zacks Consensus Estimate | -0.54 | -0.57 | -2.30 | -1.96 |
Earnings ESP | 0.00% | 0.00% | 0.00% | 0.00% |
Surprise - Reported Earnings History
Quarter Ending (12/2023) |
Quarter Ending (9/2023) |
Quarter Ending (6/2023) |
Quarter Ending (3/2023) |
Average Surprise | |
---|---|---|---|---|---|
Reported | -0.44 | -0.41 | -0.50 | -0.64 | NA |
Estimate | -0.57 | -0.47 | -0.53 | -0.59 | NA |
Difference | 0.13 | 0.06 | 0.03 | -0.05 | 0.04 |
Surprise | 22.81% | 12.77% | 5.66% | -8.47% | 8.19% |
Quarterly Estimates By Analyst
Zacks Premium Subscription Required Learn more
Annual Estimates By Analyst
Zacks Premium Subscription Required Learn more